Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

OnabotulinumtoxinA for the treatment of headache.

Ashkenazi A, Blumenfeld A.

Headache. 2013 Sep;53 Suppl 2:54-61. doi: 10.1111/head.12185. Review.

PMID:
24024603
[PubMed - indexed for MEDLINE]
2.

Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.

Winner PK, Sadowsky CH, Martinez WC, Zuniga JA, Poulette A.

Headache. 2012 Sep;52(8):1219-25. doi: 10.1111/j.1526-4610.2012.02164.x. Epub 2012 May 18.

PMID:
22607530
[PubMed - indexed for MEDLINE]
3.

OnabotulinumtoxinA (BOTOX®): a review of its use in the prophylaxis of headaches in adults with chronic migraine.

Frampton JE.

Drugs. 2012 Apr 16;72(6):825-45. doi: 10.2165/11208880-000000000-00000. Review.

PMID:
22468643
[PubMed - indexed for MEDLINE]
4.

OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program.

Aurora SK, Dodick DW, Diener HC, DeGryse RE, Turkel CC, Lipton RB, Silberstein SD.

Acta Neurol Scand. 2014 Jan;129(1):61-70. doi: 10.1111/ane.12171. Epub 2013 Sep 20.

PMID:
24107267
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Insights into the mechanism of onabotulinumtoxinA in chronic migraine.

Durham PL, Cady R.

Headache. 2011 Nov-Dec;51(10):1573-7. doi: 10.1111/j.1526-4610.2011.02022.x. Review.

PMID:
22082429
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

OnabotulinumtoxinA (BOTOX®): a guide to its use in preventing headaches in adults with chronic migraine.

Lyseng-Williamson KA, Frampton JE.

CNS Drugs. 2012 Aug 1;26(8):717-23. doi: 10.2165/11208930-000000000-00000.

PMID:
22784019
[PubMed - indexed for MEDLINE]
7.

Method of injection of onabotulinumtoxinA for chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical program.

Blumenfeld A, Silberstein SD, Dodick DW, Aurora SK, Turkel CC, Binder WJ.

Headache. 2010 Oct;50(9):1406-18. doi: 10.1111/j.1526-4610.2010.01766.x.

PMID:
20958294
[PubMed - indexed for MEDLINE]
8.

Botulinum toxin in the treatment of rare head and neck pain syndromes: a systematic review of the literature.

Sycha T, Kranz G, Auff E, Schnider P.

J Neurol. 2004 Feb;251 Suppl 1:I19-30. Review.

PMID:
14991339
[PubMed - indexed for MEDLINE]
9.

OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.

Aurora SK, Winner P, Freeman MC, Spierings EL, Heiring JO, DeGryse RE, VanDenburgh AM, Nolan ME, Turkel CC.

Headache. 2011 Oct;51(9):1358-73. doi: 10.1111/j.1526-4610.2011.01990.x. Epub 2011 Aug 29.

PMID:
21883197
[PubMed - indexed for MEDLINE]
10.

Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders.

Blumenfeld A.

Headache. 2003 Sep;43(8):853-60.

PMID:
12940806
[PubMed - indexed for MEDLINE]
11.

A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study.

Mathew NT, Jaffri SF.

Headache. 2009 Nov-Dec;49(10):1466-78. doi: 10.1111/j.1526-4610.2009.01566.x.

PMID:
19912346
[PubMed - indexed for MEDLINE]
12.

OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline.

Silberstein SD, Blumenfeld AM, Cady RK, Turner IM, Lipton RB, Diener HC, Aurora SK, Sirimanne M, DeGryse RE, Turkel CC, Dodick DW.

J Neurol Sci. 2013 Aug 15;331(1-2):48-56. doi: 10.1016/j.jns.2013.05.003. Epub 2013 Jun 19.

PMID:
23790235
[PubMed - indexed for MEDLINE]
13.

Treatment of chronic migraine headache with onabotulinumtoxinA.

Gerwin R.

Curr Pain Headache Rep. 2011 Oct;15(5):336-8. doi: 10.1007/s11916-011-0202-6. Review.

PMID:
21547527
[PubMed - indexed for MEDLINE]
14.

An exploratory study of salivary calcitonin gene-related peptide levels relative to acute interventions and preventative treatment with onabotulinumtoxinA in chronic migraine.

Cady R, Turner I, Dexter K, Beach ME, Cady R, Durham P.

Headache. 2014 Feb;54(2):269-77. doi: 10.1111/head.12250. Epub 2013 Oct 22.

PMID:
24147647
[PubMed - indexed for MEDLINE]
15.

The Use of Botulinum Toxin Type A in Headache Treatment.

Mathew NT, Kaup AO.

Curr Treat Options Neurol. 2002 Sep;4(5):365-373.

PMID:
12162925
[PubMed - as supplied by publisher]
16.

Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine.

Robertson CE, Garza I.

Neuropsychiatr Dis Treat. 2012;8:35-48. doi: 10.2147/NDT.S17923. Epub 2012 Jan 13.

PMID:
22275844
[PubMed]
Free PMC Article
17.

Botulinum neurotoxin in the treatment of headache disorders.

Mauskop A.

Handb Clin Neurol. 2010;97:217-32. doi: 10.1016/S0072-9752(10)97017-6.

PMID:
20816423
[PubMed - in process]
18.

OnabotulinumtoxinA in pediatric chronic daily headache.

Kabbouche M, O'Brien H, Hershey AD.

Curr Neurol Neurosci Rep. 2012 Apr;12(2):114-7. doi: 10.1007/s11910-012-0251-1.

PMID:
22274570
[PubMed - indexed for MEDLINE]
19.

Botulinum toxin type A for migraine. First, do no harm.

[No authors listed]

Prescrire Int. 2011 Dec;20(122):287-90.

PMID:
22216539
[PubMed - indexed for MEDLINE]
20.

Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside.

Dodick DW.

Headache. 2003 Jul-Aug;43 Suppl 1:S25-33. Review.

PMID:
12887391
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk